Syneos Health and uMotif Partner to Deliver Patient-centric eClinical Platform
June 26, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., June 26, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with...
Syneos Health Appoints Batisha Anson to Global Head, Patient Diversity and Health Equity
May 25, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 25, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the appointment of Batisha...
Syneos Health Leaders Recognized by HBA
May 17, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 17, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced that Jennifer Sozio, SVP...
Syneos Health Leaders Recognized as PM360 2023 ELITE Award Recipients
May 16, 2023 08:05 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced PM360 has named Maria Fotiu,...
Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023
April 13, 2023 16:31 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 13, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, will release its first quarter 2023 financial...
Syneos Health Wins 2023 ViE Award
April 05, 2023 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced it has been awarded...
Syneos Health Reports Fourth Quarter and Full Year 2022 Results
February 16, 2023 06:03 ET
|
Syneos Health, Inc.
Revenue for the fourth quarter of $1,359.9 million decreased 1.0% on a reported basis and increased 1.7% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023 16:31 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health Extends Partnership with Medable
December 13, 2022 07:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it has extended its strategic...
Syneos Health Reports Third Quarter 2022 Results
November 04, 2022 06:10 ET
|
Syneos Health, Inc.
Revenue for the third quarter of $1,336.2 million decreased 0.9% on a reported basis and increased 2.2% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...